GemPharmatech Co (SHSE:688046) Construction In Progress: ¥24.8 Mil (As of Mar. 2026)


SHSE:688046 GemPharmatech Co Ltd SHSE:688046
95 GF Score
Price ¥23.22
GF Value ¥19.45
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is GemPharmatech Co Construction In Progress?

GemPharmatech Co SHSE:688046 -1.61% 95 Construction In Progress is ¥24.8 Mil as of Mar. 2026. GuruFocus rates SHSE:688046 with a GF Score™ of 95/100 and a GF Value™ of ¥19.45 (Modestly Overvalued). The stock has 8 warning signs investors should review.

GemPharmatech Co's quarterly construction in progress declined from Sep. 2025 (¥118.7 Mil) to Dec. 2025 (¥22.5 Mil) but then increased from Dec. 2025 (¥22.5 Mil) to Mar. 2026 (¥24.8 Mil).

GemPharmatech Co's annual construction in progress increased from Dec. 2023 (¥89.6 Mil) to Dec. 2024 (¥90.9 Mil) but then declined from Dec. 2024 (¥90.9 Mil) to Dec. 2025 (¥22.5 Mil).

GemPharmatech Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for GemPharmatech Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GemPharmatech Co Construction In Progress Chart

GemPharmatech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial 53.02 171.67 89.60 90.85 22.46

GemPharmatech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.03 112.27 118.66 22.46 24.77
SHSE:688046
95GF Score
GemPharmatech Co Ltd SHSE:688046
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GemPharmatech Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥24.8 Mil mean?
GemPharmatech Co (SHSE:688046) has a Construction In Progress of ¥24.8 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on GemPharmatech Co and its competitors.
Is GemPharmatech Co's Construction In Progress too high?
GemPharmatech Co's current Construction In Progress is ¥24.8 Mil. Overall, GemPharmatech Co has a GF Score™ of 95/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GemPharmatech Co's Construction In Progress compare to VRTX and REGN?
GemPharmatech Co's Construction In Progress of ¥24.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on GemPharmatech Co and its competitors. GemPharmatech Co's current Construction In Progress is ¥24.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GemPharmatech Co stock overvalued right now?
Based on GuruFocus' analysis, GemPharmatech Co (SHSE:688046) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥19.45, compared to a current price of ¥23.22 — trading 19.4% above its estimated fair value. The current Construction In Progress is ¥24.8 Mil. GemPharmatech Co's overall GF Score™ is 95/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For GemPharmatech Co (SHSE:688046), the current Construction In Progress is ¥24.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GemPharmatech Co (SHSE:688046) Overvalued in 2026?

Based on GuruFocus' analysis, GemPharmatech Co stock appears to be overvalued. The current stock price of ¥23.22 is trading 19.4% above its estimated GF Value™ of ¥19.45. GuruFocus considers GemPharmatech Co to be Modestly Overvalued.

Key valuation signals for SHSE:688046:

  • Construction In Progress: ¥24.8 Mil
  • GF Value™: ¥19.45 vs. price of ¥23.22 (19.4% above fair value)
  • GF Score™: 95/100 with 8 warning signs

No single metric tells the full story. See the SHSE:688046 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GemPharmatech Co Business Description

Address No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032
GemPharmatech Co Ltd is a provider of genetically engineered mouse models and services to preclinical research and development communities. The company develops mouse models with independent intellectual property rights based on technical platforms such as gene editing, stem cells, phenotypic analysis, efficacy analysis, and sterile animals, and carries out one-stop services such as model customization, customized breeding, and functional efficacy analysis.
95GF Score

Get the complete analysis for SHSE:688046

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.22
Price
¥19.45
GF Value